Comerica Bank
RGNX icon

Comerica Bank’s Regenxbio RGNX Stock Holding History

Comerica Bank’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13,932
Closed -$146K – 3733
2024
Q3 		$146K Sell
13,932
-396
-3% -$4.83K ﹤0.01% 2413
2024
Q2 		$168K Sell
14,328
-466
-3% -$7.25K ﹤0.01% 2333
2024
Q1 		$312K Sell
14,794
-1,256
-8% -$22.4K ﹤0.01% 2101
2023
Q4 		$288K Sell
16,050
-54
-0.3% -$951 ﹤0.01% 2113
2023
Q3 		$265K Buy
+16,104
New +$292K ﹤0.01% 2095
2022
Q4 		$484K Sell
20,633
-6,495
-24% -$147K ﹤0.01% 1791
2022
Q3 		$602K Sell
27,128
-3,555
-12% -$105K 0.01% 1708
2022
Q2 		$970K Buy
30,683
+185
+0.6% +$4.62K 0.01% 1542
2022
Q1 		$944K Buy
30,498
+1,405
+5% +$39K 0.01% 1613
2021
Q4 		$760K Sell
29,093
-3,205
-10% -$109K 0.01% 1699
2021
Q3 		$1.17M Buy
32,298
+1,072
+3% +$38.6K 0.01% 1607
2021
Q2 		$908K Sell
31,226
-2,436
-7% -$87.1K 0.01% 1769
2021
Q1 		$1.15M Buy
33,662
+3,398
+11% +$145K 0.01% 1695
2020
Q4 		$1.31M Sell
30,264
-96
-0.3% -$3.35K 0.01% 1557
2020
Q3 		$876K Sell
30,360
-2,050
-6% -$66.8K 0.01% 1639
2020
Q2 		$1.23M Buy
32,410
+1,825
+6% +$68K 0.01% 1387
2020
Q1 		$1.27M Buy
30,585
+1,143
+4% +$47.6K 0.01% 1196
2019
Q4 		$1.31M Buy
29,442
+117
+0.4% +$4.62K 0.01% 1377
2019
Q3 		$1.13M Buy
29,325
+490
+2% +$19.9K 0.01% 1453
2019
Q2 		$1.38M Sell
28,835
-1,516
-5% -$75.7K 0.01% 1341
2019
Q1 		$1.7M Buy
30,351
+996
+3% +$49.3K 0.01% 1236
2018
Q4 		$1.23M Buy
29,355
+786
+3% +$46.1K 0.01% 1423
2018
Q3 		$1.69M Buy
28,569
+214
+0.8% +$15.4K 0.01% 1255
2018
Q2 		$2.23M Buy
+28,355
New +$1.35M 0.02% 1192

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Comerica Bank's RGNX Position: Q4 2024 in Review

Comerica Bank sold out of Regenxbio (RGNX) in Q4 2024, closing a stake of 13,932 shares — an estimated $146K sold.

Comerica Bank first reported a position in RGNX in Q2 2018 and held it in 24 quarters. The position peaked at $2.23M in Q2 2018. 177 funds tracked by Wall St. Rank hold RGNX as of Q4 2024.

  • Comerica Bank reported no remaining Regenxbio position as of Q4 2024 after selling out during the quarter.
  • Comerica Bank sold 13,932 Regenxbio shares in Q4 2024, an estimated $146K.
  • Comerica Bank first reported a position in Regenxbio in Q2 2018 and held it in 24 quarters.
  • Comerica Bank's Regenxbio position peaked at $2.23M in Q2 2018.
  • 177 funds tracked by Wall St. Rank held Regenxbio as of Q4 2024.

Based on Comerica Bank's 13F filing for Q4 2024, filed 14 Feb 2025.